a Novel Index for Tissue Perfusion in Predicting Outcome in Patients With Septic Shock
The Reliability of a Novel Index for Tissue Perfusion in Predicting Outcome in Patients With Septic Shock: a Prospective Observational Study.
1 other identifier
observational
34
1 country
1
Brief Summary
Septic shock is a life-threatening condition with mortality rate of up to -40%. Septic shock is catheterized by altered microcirculation that leads to tissue hypoperfusion and ultimately multi-organ dysfunction. Hence, maintenance of adequate tissue perfusion is the mainstay of resuscitation of patients with septic shock. Serum lactate is still considered the gold standard for evaluation of tissue perfusion. Thus, according to the latest definition, elevated serum lactate, as an indicator of tissue hypo-perfusion, is required for diagnosis of septic shock. However, lactate level change in response to resuscitation is slow even in survivors. Capillary refill time (CRT) is a simple method for assessing peripheral perfusion. Monitoring CRT was found to be a good tool for guiding resuscitation and delayed CRT showed good ability in predicting mortality in patients with septic shock. To the best of our knowledge, there is no previous report assessing the reliability of an index that include both serum lactate and CRT (lactate/CRT index) in predicting mortality in patients with septic shock. We hypothesize that the lactate/CRT index would have good accuracy in predicting mortality in patient with septic shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 13, 2022
CompletedFirst Posted
Study publicly available on registry
March 21, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2022
CompletedMarch 21, 2022
March 1, 2022
3 months
March 13, 2022
March 13, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
the ability of Lactate/CRT index in predicting patient's outcome
multiplying the CRT and serum lactate
6 hour after admission
Secondary Outcomes (5)
ability of Lactate/CRT index in predicting patient's outcome
12 hours after admission
ability of Lactate in predicting patient's outcome
6 and 12 hours after admission
ability of CRT in predicting patient's outcome
6 and 12 hours after admission
change in serum lactate
WITHIN 1 HOUR, 6 and 12 hours after admission
change in CRT
WITHIN 1 HOUR, 6 and 12 hours after admission
Interventions
index will be calculated as the product of multiplying the CRT and serum lactate
Eligibility Criteria
All consecutive patients with clinically suspected septic shock according to the latest definition of septic shock (sepsis-3) "hypotension in a patient with sepsis requiring vasopressor therapy to maintain mean arterial pressure above 65 mmHg despite adequate fluid resuscitation in addition to elevated serum lactate level (above 2 mmol/L)"
You may qualify if:
- Patients with clinically suspected septic shock, older than 18 years old
You may not qualify if:
- Patients less than 18 years.
- patients with evident blood loss.
- patients with metastatic cancer.
- Patients with Child B or C liver cirrhosis
- patients with estimated glomerulo filtartion rate less than 30 ml/min/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Cairo University
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
ahmed hasanin
Cairo University Kasr Alainy Faculty of Medicine
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 13, 2022
First Posted
March 21, 2022
Study Start
March 1, 2022
Primary Completion
June 1, 2022
Study Completion
June 1, 2022
Last Updated
March 21, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share
the protocol and data supporting this study will be available from the PI upon reasonable request